Background: Mycophenolate mofetil is used for the prevention of solid organ transplant rejection and for other indications, such as systemic lupus erythematosus (SLE).
Objective: To determine the prescription patterns of mycophenolate mofetil in a group of Colombian patients.
Methods: This was a cross-sectional study of patients receiving mycophenolate mofetil between 2021 and 2022.